Screening for prostate cancer

Rosalyn W Stewart; Sergio Lizama; Kimberly Peairs; Heather F Sateia; Youngjee Choi

doi:10.1053/j.seminoncol.2017.02.001

Screening for prostate cancer

Semin Oncol. 2017 Feb;44(1):47-56. doi: 10.1053/j.seminoncol.2017.02.001. Epub 2017 Feb 11.

Authors

Rosalyn W Stewart¹, Sergio Lizama², Kimberly Peairs³, Heather F Sateia⁴, Youngjee Choi⁴

Affiliations

¹ Johns Hopkins University School of Medicine, Department of Medicine, Division of General Internal Medicine, Baltimore, MD. Electronic address: rstewart@jhmi.edu.
² Saint Agnes Healthcare, Baltomore, MD.
³ Johns Hopkins University School of Medicine, Department of Medicine, Division of General Internal Medicine, Baltimore, MD; Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD.
⁴ Johns Hopkins University School of Medicine, Department of Medicine, Division of General Internal Medicine, Baltimore, MD.

PMID: 28395763
DOI: 10.1053/j.seminoncol.2017.02.001

Abstract

This review comprises a general overview of the impact and risk factors for prostate cancer. Evidenced-based professional society prostate cancer screening guideline recommendations are reviewed, and our approach to a case is presented.

Keywords: Cancer screening; Prevention; Primary care; Prostate cancer; Screening guidelines.

Publication types

Case Reports
Review

MeSH terms

Digital Rectal Examination
Early Detection of Cancer / methods*
Humans
Male
Middle Aged
Practice Guidelines as Topic
Prostate-Specific Antigen / blood
Prostatic Neoplasms / diagnosis*
Prostatic Neoplasms / etiology
Risk Factors

Substances

Prostate-Specific Antigen